Israeli drugmaker Teva to pay Oklahoma $85m in opioid suit
Pharmaceutical titan Johnson & Johnson is set to go on trial in the state on Tuesday after declining to settle
Washington — Israeli pharmaceutical giant Teva has agreed to pay the US state of Oklahoma $85m to settle a lawsuit, accusing it of fuelling the state’s opioid epidemic, Oklahoma’s attorney-general said. The announcement comes after Purdue Pharma, maker of the opioid painkiller OxyContin — a key driver of the crisis responsible for tens of thousands of deaths in the US — reached a $270m settlement with the state in March. Attorney-general Mike Hunter said in a statement on Sunday the Teva settlement shows Oklahoma’s “resolve to hold the defendants in this case accountable for the ongoing opioid overdose and addiction epidemic that continues to claim thousands of lives each year”. The money will be used by the mid-western state to fight the opioid crisis, Hunter said, with an announcement of how exactly it will be spent to be made in the future. Meanwhile, another pharmaceutical titan, Johnson & Johnson, is set to go on trial in Oklahoma on Tuesday, with the company facing similar acc...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.